Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Thrombosis Research|October 23, 2015
Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparinAurélie Rousseau, Patrick Van Dreden, Elisabeth Mbemba, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 20, 2004
Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasmaGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Thrombosis Research|February 2, 2020
Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cellsRania AmraneDjedidi, Aurélie Rousseau, Annette K Larsen, et al.
International Journal of Oncology|October 28, 2017
Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cellsAurélie Rousseau, Annette K Larsen, Patrick Van Dreden, et al.
International Journal of Oncology|October 28, 2017
Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancerAurélie Rousseau, Patrick Van Dreden, Amir Khaterchi, et al.
Thrombosis Research|December 4, 2015
Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonistsEmmanuel Mathieu, Patrick Van Dreden, Jérôme Aulagnier, et al.
British Journal of Haematology|October 31, 2009
Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemiaPascale Schneider, Patrick Van Dreden, Aurélie Rousseau, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2005
Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor XIkuko Isshiki, Remi Favier, Takanori Moriki, et al.
Thrombosis Research|April 22, 2011
Decreased activity of soluble thrombomodulin and plasma procoagulant phospholipids in childhood bone marrow transplantation with severe complicationsPascale Schneider, Patrick Van Dreden, Aurélie Rousseau, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 10, 2016
The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1Mouna Sassi, Taher Chakroun, Elisabeth Mbemba, et al.
Pageof 6